Relationship between hormone receptor concentration and tumor shrinkage in uterine myoma after treatment with a GnRHa

Chinese Medical Journal (Taipei)

Volumn 62, Issue 5, 1999, Pages 294-299

  Wang, Peng Hui ^a   Lee, Wen Ling ^a   Chao, Hsiang Tai ^a   Shu, Li Ping ^a   Kao, Hwa Li ^a   Wu, Chiu Wen ^a   Yuan, Chiou Chung ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Estrogen receptors; Gonadotropin releasing hormone agonist; Progesterone receptors; Uterine myoma

Indexed keywords

ESTROGEN RECEPTOR; GONADORELIN AGONIST; GOSERELIN; HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HORMONAL THERAPY; HOT FLUSH; HUMAN; MYOMECTOMY; PREMENOPAUSE; SEXUAL DYSFUNCTION; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR REGRESSION; ULTRASOUND; UTERUS MYOMA;

ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; GOSERELIN; HUMANS; LEIOMYOMA; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; UTERINE NEOPLASMS;

EID: 0033035876     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981;36: 433-45.
2. Farber M, Conrad S, Heinrichs W. Estradiol binding by myoma tumors and normal myometnum. Obstet Gynecol 1972;40:479-86.
3. Wilson EA, Yang F, Rees ED. Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues. Obstet Gynecol 1980;55:20-4.
4. Lumsden MA, West RA, Hawkins TA. The binding of steroids to myometrium and leiomyomata (myomas) in women treated with the gonadotropin-releasing hormone agonist Zoladex (ICI 1188630). J Endocrinol 1989;121: 389-96.
5. Fernandez-Montoli MF, Balaguero L, Diez-Gibert O. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and myoma after gonadotropin-releasing hormone agonist treatment. Fertil Steril 1995;63:522-7.
6. Pasqualini JR, Vella C, Cornier E. Effect of decapetyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium. Fertil Steril 1990;53: 1012-7.
7. Filicori M, Hall DA, Loughlin JS. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing analogue. Am J Obstet Gynecol 1983;147:726-7.
8. Maheux R, Guilloteau C, Lemay A. Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study. Am J Obstet Gynecol 1985;152:1034-8.
9. Coddington CC, Collins RL, Shawker TH. Long-acting gonadotropin hormone-releasing hormone analogue used to treat uteri. Fertil Steril 1986;45:624-9.
10. West CP, Lumsden MA, Lawson S. Shrinkage of uterine myomas during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil Steril 1987;48:45-51.
11. Colgan TJ, Pendergast S, Leblanc M. The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues. Hum Pathol 1993;24: 1073-7.
12. Rein MS, Friedman AJ, Stuart JM, MacLaughlin DT. Myoma and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertil Steril 1990;53:1018-23.
13. Wu CW, Chi CW, Chang TI. Sex hormone receptors in gastric cancer. Cancer 1990;65:1396-400.
14. Wu CW, Chang HM, Kao HL. The nontransformed progesterone and estrogen receptors in gastric cancer. Gastroenterology 1992;102:1639-46.
15. Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 1949;51:660-72.
16. Hartree EF. Determination of protein: a modification of the Lowry method that gives a liner photometric response. Ann Biochem 1972;48:422-7.
17. Friedman AJ, Daly M, Juneau-Norcross M, Gleason R, Rein MS, LeBoff M. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years. Hum Reprod 1994;9:1618-25.
18. Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995;172:14-8.
19. Rein MS, Friedman AJ, Stuart JM, MacLaughlin DT. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist. Fertil Steril 1992;58:413-5.